. Some studies have suggested that the application of direct electrical current (DEC) to a tumour results in damage to tumour tissue (Nordenstrom, 1978 (Nordenstrom, , 1985 Habal, 1980; Yokoyama et al., 1989; Azavedo et al., 1991) . It is well known that the applition of appropriate amounts of DEC can induce vascular thrombosis (Sawyer et al., 1960; Strachan et al., 1974; Taylor & Neilson, 1981) (Figure 4 ).
Hwnan studies
Anal condylomata One day after treatment the lesions appeared swollen and developed a bluish discoloration. After 2 weeks the treated condylomata had been reduced to about 20% of their original size, and by 3 weeks they had virtually disappeared ( Figure 5 ). later showed evidence of tumour destruction, particularly in relation to the electrodes. However, some tumour emuained and the patient died some 3 weeks later. A post-mortem examination reported extensive, virtually full-thickness, necrosis of the adenocarcinoma extending from its junction with the proximal oesophagus to its distal extension in the gastric wall. The necrosis was not pronounced along sites corresponding to the longitudinal electrodes ( Figure 6 ). Visible tumour was present in some submucosal and deep lymphatics within the musculans propria of the gastric cardia. There was a marked fibroblastic response within the lumina of many of the small arteries and arterioles within the tumour and bowel wall consistent with the organisation of recent thrombi. The right renal vessels were thrombosed and there was some thrombosis in the inferior vena cava. There was no perforation of the area of extensive tumour necrosis. Most importantly, there was necrosis of tumour in the paraoesophageal and left gastric lymph nodes which were draining the tumour.
Patient 4 After the first 45 min treatment oedema and whitening of the lesion was observed with central necrosis (Figure 7) . The second treatment, 48 h later, resulted in marked and extensive necrosis of the lesion. Long-term observation was not possible because of death of the patient from intercurrent pneumonia, unrelated to DEC therapy.
The mechanism by which DEC produces tissue damage is not fully understood. The application of direct current to a blood vessel has for long been known to produce thrombosis at the anode (Taylor & Nielson, 1981) . A logical result of these observations on venous thrombosis would be to produce extensive thrombosis of tumour circulation, which might be more vulnerable to DEC, because of angiogenesis, by passing a greater quantity of DEC through the tumour tissue. Such a philosophy might produce thrombosis in veins, small arteries and arterioles of a vulnerable hyperdynamic tumour circulation. Our observations that the tumour necrosis effects of DEC extended to produce necrosis of adjacent lymph nodes are difficult to explain but may be due to sharing of a common blood supply with adjacent tumour tissue.
The direct cytopathic effects of DEC may perhaps occur by alteration of membrane potential and interference with biochemical activity that is germane to tumour growth or survival. We are certain that biochemical changes take place at the electrodes, though it is conceivable that these are secondary to cell destruction produced by DEC rather than to the precise local mechanism inducing that necrosis. A total of 80mA of DEC, the most we have used, passed for a period of 1 h, at a potential difference of 7 V, is not sufficient to generate heat necessary to produce a hyperthermic effect (Samuelson & Jonsson, 1980) . We have placed multiple thermocouples but have not been able to demonstrate a heating effect.
By changing the charge on the venous endothelium, platelet aggregation is induced at the electrode, which could go on to produce vascular occlusion by the development of a laminated propagating thrombosis. An alternative mechanism might be that of endothelial damage produced by electrical change and biochemical abnormalities in the tissues immediately adjacent to the electrodes. We have demonstrated the development, by 24 h, of highly specific and reproducible changes in the serum biochemistry of mice: low serum sodium, high serum potassium, low serum calcium, low plasma glucose, raised blood urea and raised serum creatinine (Griffin et al., 1994) . Whatever the exact mechanism, vascular occlusion by thrombus can undoubtedly be reliably produced by the passage of an appropriate quantity of electrical current. The development of damage to the oesophageal mucosa in the dog developed over a period of about 7 days after treatment. Endoscopy performed on the dogs on completion of the application of current showed no change; the ischaemic tissue presumably then underwent autolysis over the ensuing 10 days. The area of tissue destruction corresponded accurately to the size and shape of the electrodes, which could be designed in such a way as to be accurately applied to the tumour tissue to be treated, in a highly specific way.
Studying the effect of the application of direct current to condylomata acuminata gave us a tumour which was easily accessible and could be accurately monitored in assessing the effects of the therapy. On completion of the,treatment no immediate effect was observed. The following day the tumours were oedematous and discoloured; by 2 weeks they had been completely destroyed. No recurrences occurred over the subsequent 6 months. The skin adjacent to the base of the condylomata was not damaged. The only side-effect was some superficial skin blistering that corresponded to the site of application of the negative electrode, which was separated from the skin by a pad soaked in hypotonic saline.
The spread of disease at presentation in a high proportion of patients with oesophageal and other carcinomata is often too great for curative or even palliative surgical resection. Management of these patients raises many problems. In the case of advanced oesophageal cancer, oesophageal dilatation and intubation of the malignant stricture is associated with a significant mortality and morbidity (Amman & Collis, 1970; Atkinson & Ferguson. 1977 ).
The animal experiments descnrbed here have shown that by the application of direct electrical current it is possible accurately and predictably to destroy the tissue in the region of the electrode. By thrombosing the local tumour circulation it is possible to produce extensive tumour destruction and also to destroy the adjacent tumour-associated lymph nodes. The treatment can be repeated as required following the development of further tumour or when repeat endoscopy reveals recurrence. Our limited experience to date has suggested that the application of 20 mA per electrode for a period of 1 h is safe in that the depth of penetration will not lead to oesophageal perforation. The application of these electrodes does seem to stimulate the production of mucus, which may be troublesome for several days after treatment.
Even if the application of direct current could not be used to treat accurately extensions of neoplasm or metastases, it may provide a useful adjunctive role for tumour debulking. The observation of reduction of tumour mass in adjacent lymph nodes is of major interest since it would appear that the application of direct electrical current may affect contiguous extension of neoplasia by mechanisms which are as yet unclear. The tumour necrosis found in patient 3 in adjacent lymph nodes was far greater than could be anticipated from spontaneous foci of necrosis that may be encountered, especially in large metastases, when the tumour naturally outstrips its blood supply.
No treatment currently exists for Kaposi's sarcoma, a disfiguring tumour that is of increasing prevalence as a consequence of the AIDS pandemic. It is possible that Kaposi's sarcoma is particularly amenable to DEC because of its primary vascular nature.
We believe that there is a great therapeutic potential for the development of this new technology. If further studies can confirm the beneficial effects of direct electrical current on hyperplastic and malignant tissue that we have observed in these studies, then the application of relatively small amounts of direct electrical current using a variety if purpose-designed delivery probes could produce an innovative low-cost treatment alternative for patients with malignant disease that is accessible to the application of this technology.
